Cyclopropanol Warhead in Malleicyprol Confers Virulence of Human- and Animal-Pathogenic Burkholderia Species.
Felix TrottmannJakob FrankeIngrid RichterKeishi IshidaMichael CyruliesHans-Martin DahseLars RegesteinChristian HertweckPublished in: Angewandte Chemie (International ed. in English) (2019)
Burkholderia species such as B. mallei and B. pseudomallei are bacterial pathogens causing fatal infections in humans and animals (glanders and melioidosis), yet knowledge on their virulence factors is limited. While pathogenic effects have been linked to a highly conserved gene locus (bur/mal) in the B. mallei group, the metabolite associated to the encoded polyketide synthase, burkholderic acid (syn. malleilactone), could not explain the observed phenotypes. By metabolic profiling and molecular network analyses of the model organism B. thailandensis, the primary products of the cryptic pathway were identified as unusual cyclopropanol-substituted polyketides. First, sulfomalleicyprols were identified as inactive precursors of burkholderic acid. Furthermore, a highly reactive upstream metabolite, malleicyprol, was discovered and obtained in two stabilized forms. Cell-based assays and a nematode infection model showed that the rare natural product confers cytotoxicity and virulence.
Keyphrases
- antimicrobial resistance
- pseudomonas aeruginosa
- escherichia coli
- staphylococcus aureus
- biofilm formation
- single cell
- endothelial cells
- healthcare
- cystic fibrosis
- molecular docking
- high throughput
- cell therapy
- transcription factor
- stem cells
- copy number
- gene expression
- induced pluripotent stem cells
- candida albicans
- single molecule
- pluripotent stem cells
- genome wide identification